[go: up one dir, main page]

PL406051A1 - Application of probiotic composition - Google Patents

Application of probiotic composition

Info

Publication number
PL406051A1
PL406051A1 PL406051A PL40605113A PL406051A1 PL 406051 A1 PL406051 A1 PL 406051A1 PL 406051 A PL406051 A PL 406051A PL 40605113 A PL40605113 A PL 40605113A PL 406051 A1 PL406051 A1 PL 406051A1
Authority
PL
Poland
Prior art keywords
probiotic composition
application
treatment
preparation
composition
Prior art date
Application number
PL406051A
Other languages
Polish (pl)
Other versions
PL236218B1 (en
Inventor
Piotr B. Heczko
Magdalena Strus
Grzegorz Stefański
Katarzyna Dechnik
Ewa Jabłońska-Mróz
Original Assignee
Instytut Biotechnologii Surowic I Szczepionek Biomed Spółka Akcyjna
Prolab Spółka Z Ograniczoną Odpowiedzialnością, Spółka Komandytowa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biotechnologii Surowic I Szczepionek Biomed Spółka Akcyjna, Prolab Spółka Z Ograniczoną Odpowiedzialnością, Spółka Komandytowa filed Critical Instytut Biotechnologii Surowic I Szczepionek Biomed Spółka Akcyjna
Priority to PL406051A priority Critical patent/PL236218B1/en
Publication of PL406051A1 publication Critical patent/PL406051A1/en
Publication of PL236218B1 publication Critical patent/PL236218B1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Przedmiotem wynalazku jest zastosowanie kompozycji probiotycznej do wspomagania leczenia zapalenia jelit. Kompozycja zawiera trzy szczepy bakterii kwasu mlekowego Lactobacillus rhamnosus KL 53A, Lactobacillus plantarum PL02 i Bifidobacterium longum PL03, wykazujące zdolność wpływania na profil cytokinowy do wytwarzania preparatu użytecznego w profilaktyce i leczeniu stanu zapalnego jelit.The present invention relates to the use of a probiotic composition to assist in the treatment of enteritis. The composition contains three strains of lactic acid bacteria Lactobacillus rhamnosus KL 53A, Lactobacillus plantarum PL02 and Bifidobacterium longum PL03, showing the ability to influence the cytokine profile for the preparation of a preparation useful in the prevention and treatment of intestinal inflammation.

PL406051A 2013-11-13 2013-11-13 Application of probiotic composition PL236218B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL406051A PL236218B1 (en) 2013-11-13 2013-11-13 Application of probiotic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL406051A PL236218B1 (en) 2013-11-13 2013-11-13 Application of probiotic composition

Publications (2)

Publication Number Publication Date
PL406051A1 true PL406051A1 (en) 2015-05-25
PL236218B1 PL236218B1 (en) 2020-12-28

Family

ID=53175996

Family Applications (1)

Application Number Title Priority Date Filing Date
PL406051A PL236218B1 (en) 2013-11-13 2013-11-13 Application of probiotic composition

Country Status (1)

Country Link
PL (1) PL236218B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12458672B2 (en) 2016-02-04 2025-11-04 Universiteit Gent Use of microbial communities for human and animal health

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12458672B2 (en) 2016-02-04 2025-11-04 Universiteit Gent Use of microbial communities for human and animal health

Also Published As

Publication number Publication date
PL236218B1 (en) 2020-12-28

Similar Documents

Publication Publication Date Title
BR112014025469A2 (en) use of probiotic bacteria in the treatment of bacterial infections and skin regeneration, as well as compositions comprising strains of said bacteria
ZA202105310B (en) Probiotic compositions comprising lactobacillus reuteri strains and methods of use
EP4364745A3 (en) Novel lactic acid bacteria and use thereof
PH12016501953A1 (en) Pediatric nutritional composition with human milk oligosaccharides, prebiotics and probiotics
EA201891908A1 (en) APPLICATION OF PROBIOTICS FOR THE TREATMENT AND / OR PREVENTION OF PSORIASIS
EA201390305A1 (en) COMPOSITIONS FOR MOISTURAL AND ORAL INTAKE OF LACTOBACILLUS AND THEIR APPLICATION
PL2364712T3 (en) Topical cosmetic or pharmaceutical composition comprising probiotic lactobacillus strains and use of same
PE20190417A1 (en) USE OF PROBIOTICS IN THE TREATMENT AND / OR PREVENTION OF ATOPIC DERMATITIS
DK2802333T3 (en) Lactobacillus rhamnosus and Bifidobacterium animalis subsp. lactis for use in the prevention or treatment of upper respiratory tract infections
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain
IT201600091033A1 (en) Strains of probiotic bacteria belonging to the genus Bifidobacterium and their extracts of probiotic cells (ECP) having immunostimulant properties.
DK3554517T3 (en) PROBIOTIC COMPOSITION COMPRISING LACTOBACILLUS RHAMNOSUS AND LACTOBACILLUS PARACASEI STRAINS
MX383749B (en) PROBIOTIC STRAINS WITH THE ABILITY TO ABSORB CHOLESTEROL, METHODS AND USES OF THEM
MX382895B (en) DIETARY SUPPLEMENT.
ZA201804863B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
EA201291440A1 (en) PROBIOTIC STRAINS FOR APPLICATION TO IMPROVE TRANSEPSIAL RESISTANCE
WO2019098810A3 (en) Novel lactic acid bacteria and use thereof
CO2017007338A2 (en) Composition comprising two strains of the microbial species lactobacillus rhamnosus and bifidobacterium longum capable of increasing male fertility
PL406051A1 (en) Application of probiotic composition
MY193625A (en) Probiotic composition for treatment or prevention of high blood cholesterol
BR112015032351A2 (en) composition comprising l. rhamnosus gg
PL397178A1 (en) Probiotic composition
HK40000927A (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
RU2012102853A (en) Strain LACTOCOCCUS CASEI VKPM B-8730 USED FOR PREPARATION OF DAIRY PRODUCTS AND PROBIOTIC DRUGS
NZ724753A (en) Probiotic bacteria